deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03599713

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma (POD1UM-201)

Sponsor: Incyte Corporation

Conditions Metastatic Merkel Cell Carcinoma
Interventions Retifanlimab
Updated 31 times since 2018 Last updated: Aug 1, 2025 Started: Feb 25, 2019 Primary completion: Jan 21, 2022 Completion: Jun 28, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Metastatic Merkel Cell Carcinoma, this trial is completed. The trial is conducted by Incyte Corporation and has accumulated 31 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2018 – ~Oct 2018 · 2 months · monthly snapshot~Oct 2018 – ~Mar 2019 · 5 months · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Dec 2020 · 4 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Jun 2022 · 7 months · monthly snapshot~Jun 2022 – ~Oct 2022 · 4 months · monthly snapshot~Oct 2022 – ~Feb 2023 · 4 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Nov 2023 · 5 months · monthly snapshot~Nov 2023 – ~May 2024 · 6 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Aug 2025 · 9 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 9 months · monthly snapshot

Change History

31 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Aug 2025 — Sep 2025 [monthly]

    Completed PHASE2

  3. Nov 2024 — Aug 2025 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 26 earlier versions

  1. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Nov 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Jun 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2023 — Jun 2023 [monthly]

    Active Not Recruiting PHASE2

  5. Feb 2023 — Apr 2023 [monthly]

    Active Not Recruiting PHASE2

  6. Oct 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE2

  7. Jun 2022 — Oct 2022 [monthly]

    Active Not Recruiting PHASE2

  8. Nov 2021 — Jun 2022 [monthly]

    Active Not Recruiting PHASE2

  9. Oct 2021 — Nov 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  10. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  11. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  12. Aug 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  13. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE2

  14. Apr 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  15. Feb 2020 — Apr 2020 [monthly]

    Recruiting PHASE2

  16. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE2

  17. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE2

  18. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  19. Sep 2019 — Nov 2019 [monthly]

    Recruiting PHASE2

  20. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE2

  21. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  22. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE2

  23. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE2

  24. Mar 2019 — May 2019 [monthly]

    Recruiting PHASE2

  25. Oct 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  26. Aug 2018 — Oct 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Incyte Corporation
Data source: Incyte Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aurora, United States , Barcelona, Spain , Bari, Italy , Berlin, Germany , Boulogne-Billancourt, France , Budapest, Hungary , Buffalo, United States , Buxtehude, Germany , Calgary AB, Canada , Candiolo, Italy and 49 more locations